Hologic (HOLX) Akcija Cena
Hologic Cena
Pēdējos 19 gados Hologic ieņēmumi auga par 12,2 % gadā un sasniedza 4,10 B USD. Peļņa uz akciju auga par 12,8 % gadā pēdējos 19 gados. Hologic neto marža 13,8 % ir samazinājusies salīdzinājumā ar 33,2 % pirms dažiem gadiem. Hologic 12 mēnešu konsensa mērķa cena ir 77,52 USD, ap virs kursu par 2,0 %. No 23 analītiķiem 0 iesaka pirkt — kopējais konsenss ir Turēt.
Hologic akcijas cena
Iegūstiet šos datus caur Eulerpool API
100 000 pieprasījumu/mēn. bez maksas · bez kartes
Hologic biznesa modelis un akciju analīze
Bieži uzdotie jautājumi par Hologic akciju
The main competitors of Hologic Inc in the market include companies like Abbott Laboratories, Thermo Fisher Scientific, and Becton, Dickinson and Company.
The business model of Hologic Inc revolves around providing innovative diagnostic solutions, primarily focused on women's healthcare. Hologic develops and markets a wide range of medical devices and instruments, including imaging systems, surgical products, and molecular diagnostic assays. The company's products are designed to enable healthcare professionals to effectively screen, diagnose, and treat various conditions and diseases. Hologic is renowned for its advanced technologies in breast health, gynecology, and skeletal health, offering solutions that empower early detection and intervention. By constantly pushing the boundaries of medical technology, Hologic Inc remains committed to improving healthcare outcomes for women around the world.
Hologic Inc is primarily active in the healthcare industry, specifically in the field of diagnostic products and medical devices. With a focus on improving women's health, Hologic Inc develops and manufactures a wide range of innovative solutions. Their portfolio includes advanced imaging systems, molecular diagnostic assays, surgical instruments, and women's health screening tests. As a prominent player in the healthcare sector, Hologic Inc constantly strives to provide cutting-edge technologies and solutions to address various medical challenges.
Hologic Inc is a leading global healthcare and diagnostics company. Established in 1985, Hologic has excelled in providing innovative solutions for women's health, with a focus on early detection and treatment of breast and cervical cancers. The company's dedication to research and development has resulted in breakthrough technologies, including the introduction of the first 3D mammography system. Hologic has expanded its portfolio to include diagnostics, surgical and skeletal health, and GYN surgical products. With a strong commitment to advancing healthcare, Hologic Inc continues to make significant contributions to improving patient outcomes and quality of life.
Hologic Inc, a leading healthcare company, has achieved several significant milestones. In recent years, the company has made notable advancements in breast health solutions. They introduced the world's first 3D mammography system, which revolutionized breast cancer detection by providing clearer and more accurate images. Hologic Inc also developed the Genius™ 3D Mammography™ exam, proven to detect breast cancer at an earlier stage compared to 2D mammography alone. Furthermore, the company expanded its portfolio by acquiring Gen-Probe, a molecular diagnostics company, allowing Hologic Inc to offer a comprehensive range of diagnostic solutions. These milestones highlight Hologic Inc's commitment to innovation and improving women's healthcare outcomes.
Hologic Inc is primarily present in various countries and regions worldwide. The company has a significant presence in the United States, where it is headquartered. Additionally, Hologic Inc operates in Europe, including countries like Germany, France, Italy, and the United Kingdom. It also has a presence in Asia, particularly in countries such as China and Japan. Furthermore, Hologic Inc serves customers in Canada and Latin America, with a focus on countries like Mexico and Brazil. Overall, Hologic Inc has a global reach and aims to provide its products and services to diverse markets internationally.
Hologic Inc represents values of innovation, commitment to quality, and patient-centric approach. The corporate philosophy of Hologic Inc revolves around developing cutting-edge medical technologies to improve women's health outcomes. With a focus on providing accurate and reliable diagnostic solutions, Hologic Inc strives to empower healthcare professionals and patients alike. The company's dedication to research and development, evidence-based practices, and collaboration with healthcare experts reinforces its commitment to advancing healthcare for women globally. Hologic Inc's mission is to make a difference in people's lives through advanced healthcare solutions, making them a trusted and reliable leader in the industry.
Analītiķi pašlaik nosaka vidējo Hologic akcijas mērķa cenu 76,66 USD (mediāna: 77,52 USD), kas ir +0,9 % pret pēdējo cenu. Konsenss balstās uz 23 analītiķu vērtējumiem.
23 analītiķi pašlaik vērtē Hologic akciju: 0 iesaka pirkt, 20 turēt un 3 pārdot. 2026. gadam analītiķi sagaida, ka Hologic gūs 4,24 B USD ieņēmumus un 4,49 USD peļņu uz akciju.
Pēc pašreizējā kursa Hologic akcija maksā 67,69 EUR (76,01 USD).
Hologic akcija (HOLX) tiek kotēta 9 biržās, tostarp: NASDAQ (HOLX), London (0J5Q.L), SIX (Zürich) (HO1.SW), XETRA (HO1.DE), Frankfurt (HO1.F), München (HO1.MU), Düsseldorf (HO1.DU), Wien (HOLX.VI).
Hologic Inc is an international leading provider of medical technology products and solutions. The company, headquartered in Marlborough, Massachusetts, operates globally and is divided into four business segments: Diagnostics, Gynecology, Skeletal Health, and Aesthetics.
gaidāmā apgrozījums Hologic ir 4,24 B USD. Šis skaitlis ir balstīts uz pašreizējiem finanšu datiem un atspoguļo uzņēmuma biznesa sniegumu.
gaidāmā peļņa Hologic ir 1,01 B USD. Neto peļņa atspoguļo uzņēmuma rentabilitāti pēc visu izdevumu atskaitīšanas.
Hologic cenas un peļņas rādītājs (P/E) pašlaik ir 16,93. P/E rādītājs salīdzina pašreizējo akcijas cenu ar peļņu uz akciju un palīdz ieguldītājiem novērtēt Hologic akcijas vērtību.
Hologic cenas un apgrozījuma rādītājs (P/S) pašlaik ir 4,05. P/S rādītājs salīdzina tirgus kapitalizāciju ar gada apgrozījumu un kalpo kā Hologic akcijas vērtības mērs.
Hologic Eulerpool kvalitātes rādītājs ir 1/10.
Hologic ISIN ir US4364401012. ISIN (International Securities Identification Number) ir pasaulē unikāls vērtspapīru identifikators.
Hologic WKN ir 879100. WKN (Wertpapierkennnummer) ir sešciparu vācu vērtspapīru identifikācijas numurs.
Hologic tikeris ir HOLX. Tikeris tiek izmantots Hologic akciju tirdzniecībai biržā.
Hologic akcija
Hologic Salīdzināmo uzņēmumu grupa
Hologic Biržas kods
Hologic FIGI
Visi Hologic fundamentālie rādītāji un padziļinātā analīze
Mūsu akciju analīze par Hologic ietver svarīgus finanšu rādītājus, piemēram, apgrozījumu, peļņu, P/E rādītāju, P/S rādītāju, EBIT, kā arī informāciju par dividendēm. Turklāt mēs aplūkojam aspektus kā akcijas, tirgus kapitalizāciju, parādus, pašu kapitālu un saistības no Hologic. Ja meklējat sīkāku informāciju par šīm tēmām, piedāvājam detalizētas analīzes mūsu apakšlapās: